Category: Biolase Technology Inc.Syndicate content

Biolase expands soft-tissue laser to new markets

February 8, 2013 by MassDevice staff

Biolase wins a nod from the FDA to expand its soft-tissue laser to 19 different markets.

Biolase logo

Biolase (NSDQ:BIOL) won FDA approval for the use of its 940nm Diolase 10 laser in a range of different markets. The federal watchdog agency also cleared 80 new procedures for the device.

The Irvine, Ca-based dental laser company said it can now sell into more than 20 new markets, including ear, nose and throat, arthroscopy, dermatology, plastic surgery and ophthalmology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Dental: Biolase gains on Q4 prelims

January 22, 2013 by MassDevice staff

Dental devices maker Biolase gets some Wall Street love on positive cash flow expectations for Q4 2012.

Biolase logo

Dental laser maker Biolase (NSDQ:BIOL) released a preliminary earnings report, expecting to positive cash flow for Q4 and the full year of 2012.

The optimistic outlook sent BIOL shares up 2.2% on the day to close at $2.77 from an open of $2.70 this morning.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase wins FDA nod for soft tissue laser

October 4, 2012 by MassDevice staff

Biolase Inc. lands 510(k) clearance for its EPIC 10 diode soft tissue laser to improve patient comfort.

Biolase logo

California-based dental laser company Biolase (NSDQ:BIOL) touted FDA clearance and CE Mark approval for its EPIC 10 diode soft tissue laser to help dentists control the laser energy level and improve patient comfort.

By the numbers: The aesthetic medical device market picks up during the 2nd quarter

August 22, 2012 by MassDevice staff

Revenues for aesthetic medical device companies largely rise during the 2nd quarter, as purchasing and volume growth trend up, according to a MassDevice.com analysis.

By the numbers: The aesthetics market picks up during the 2nd quarter

The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn't necessarily translate into healthy bottom lines for all comers.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Mako Surgical details departure of senior marketing VP | Personnel Moves

July 27, 2012 by MassDevice staff

Mako Surgical plans to keep ex-marketing & sales senior vice president Steven Nunes on for 3 months following his resignation.

fired/hired

 Mako details Nunes' exit as senior VP of sales & marketing

Stryker to begin New York layoffs ahead of the medical device tax | Wall Street Beat

June 25, 2012 by MassDevice staff

Stryker's plans to cut more than 100 jobs by closing 2 New York manufacturing facilities will begin in September and continue on a rolling basis until the end of the year, just ahead of implementation of the 2.3% medical device tax.

MassDevice.com Wall Street Beat

Stryker (NYSE:SYK) is making good on plans to cut more than 100 positions by closing 2 New York manufacturing plants, moves that the company previously attributed to attempts to cut costs ahead of the coming 2.3% medical device tax.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Heart pumps: Thoratec, HeartWare devices "basically equivalent" | Wall Street Beat

May 29, 2012 by MassDevice staff

Thoratec and HeartWare will duke it out with "basically equivalent" heart pump technologies; also, venture capitalists look for devices that replace drugs; Biolase boasts a new Nasdaq ticker; plus, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp